Found: 6
Select item for more details and to access through your institution.
A PHASE 1 STUDY OF BET INHIBITION USING RG6146 IN RELAPSED/REFRACTORY (R/R) MYC-EXPRESSING DIFFUSE LARGE B CELL LYMPHOMA (DLBCL).
- Published in:
- Hematological Oncology, 2017, v. 35, p. 263, doi. 10.1002/hon.2438_134
- By:
- Publication type:
- Article
Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE-170 phase 2 trial.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 62, doi. 10.1002/hon.2437_49
- By:
- Publication type:
- Article
PEMBROLIZUMAB MONOTHERAPY IN PATIENTS WITH PRIMARY REFRACTORY CLASSICAL HODGKIN LYMPHOMA: SUBGROUP ANALYSIS OF THE PHASE 2 KEYNOTE-087 STUDY.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 136, doi. 10.1002/hon.2437_125
- By:
- Publication type:
- Article
PHASE 1B STUDY OF PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA ( RRPMBCL): UPDATED RESULTS FROM THE KEYNOTE-013 TRIAL.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 189, doi. 10.1002/hon.2438_50
- By:
- Publication type:
- Article
GIANNI BONADONNA MEMORIAL LECTURE: 'GENETIC SIGNATURES AND TARGETABLE PATHWAYS IN LYMPHOID MALIGNANCIES'.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 23, doi. 10.1002/hon.2437_1
- By:
- Publication type:
- Article
Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11.
- Published in:
- Nature, 1990, v. 347, n. 6291, p. 394, doi. 10.1038/347394a0
- By:
- Publication type:
- Article